Estimated morbimortality and costs attributable to child and adolescent obesity in Brazil from 2024 to 2060: a multistate life table study - Nilson, Eduardo Augusto Fernandes; de Oliveira, Ana Carolina Rocha; Gusmão, Bruna; Barbosa, Raphael Barreto da Conceição (medRxiv, 2024)
Introduction Childhood obesity is a major global public health issue globally and in Brazil. The impacts of childhood obesity include higher risk of disease during childhood and of obesity and non-communicable diseases in adulthood and represent an important epidemiological and economic burden to countries.Methods This study is based on the modeling of total costs of hospitalizations and the additional healthcare costs attributable to childhood obesity in the Brazilian National Health System.Results The hospitalizations of children and adolescents with obesity as a primary cause totaled Int2.6 million to the Brazilian National Health System from 2013 to 2022, demonstrating that obesity is rarely considered as a cause of hospitalization especially among children and adolescents. The additional costs of hospitalizations attributable to childhood obesity totaled Int101.5 million during the same period. The additional non-hospital, outpatient and medication cost attributable to childhood obesity in Brazil were estimated at Int6.0 million, so the total estimated healthcare costs were of approximately Int107.5 million in the last decade.Conclusion This study highlight that the costs of childhood obesity are not limited to the impacts on adult health and represent a relevant economic burden to the Brazilian National Health System and to families because of additional costs during childhood. Therefore, the prevention and control of childhood obesity is a public health priority that demands immediate and robust policies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data on the model are publicly available. Hospitalization data is available from http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sih/cnv/niuf.def and IHME